bioAffinity Technologies to present corporate update at H.C. Wainwright conference
bioAffinity Technologies will present a corporate update at the H.C. Wainwright 28th Annual Global Investment Conference. The company reports ~600,736 shares outstanding and an aggregate market value of about $5.9 million as of Sept. 2, 2026.